case 3: managing immune-related adverse effects in tnbc
Published 4 years ago • 15 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
4:40
case 3: the use of combination therapy in triple-negative breast cancer
-
2:26
case 3: metastatic triple-negative breast cancer
-
3:37
case 3: pd-l1 testing used in triple-negative breast cancer
-
5:54
case 3: treatment after progression in triple-negative breast cancer
-
5:45
case 3: atezolizumab/nab-paclitaxel for triple negative breast cancer
-
4:50
triple negative breast cancer update: immunotherapy in stage 2-3 tnbc (keynote 522 update)
-
7:56
young triple negative breast cancer diagnosis at 29 yo: 12 year survivor story
-
24:35
'triple-negative breast cancer hit me like a freight train.’ | tnbc project
-
29:22
case study: stage iii triple negative breast cancer treatment
-
49:56
optimizing the management of metastatic brca-negative, triple-negative breast cancer
-
1:00:31
latest advances in triple-negative breast cancer treatment and care
-
6:33
case 3: results of the impassion130 trial in metastatic breast cancer
-
50:33
treatment and issues for triple negative breast cancer-may 14, 2020
-
12:38
triple negative breast cancer (tnbc): treatment options and what to expect
-
1:04:28
harnessing the immune system in the treatment of triple-negative breast cancer
-
48:02
the holistic approach to combat triple negative breast cancer | brio medical webinar
-
49:41
optimizing the management of metastatic brca-negative, triple-negative breast cancer
-
2:44
impassion130: addressing immune-related aes in tnbc management
-
38:56
navigating the management of triple-negative breast cancer: immunotherapy considerations
-
28:38
managing immunotherapy-related adverse events
-
3:38
nccn animation for patients: overview of triple-negative breast cancer (tnbc)
-
22:54
testing, treating, and targeting triple negative breast cancer | 2023 west oncology conference